Toledano-Fonseca, M., Cano-Osuna, M., Elez, E., Soto-Alsar, J., Paáez, D., Fernández-Montes, A., . . . Aranda, E. (2026). Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients.
Chicago Style CitationToledano-Fonseca, M., et al. Circulating Hsa-miR-29c-3p and VEGF-A Levels Predict the Response to FOLFIRI Plus Aflibercept in Elderly Metastatic Colorectal Cancer Patients. 2026.
MLA CitationToledano-Fonseca, M., et al. Circulating Hsa-miR-29c-3p and VEGF-A Levels Predict the Response to FOLFIRI Plus Aflibercept in Elderly Metastatic Colorectal Cancer Patients. 2026.
Warning: These citations may not always be 100% accurate.